Patents by Inventor Peter Mastrangelo

Peter Mastrangelo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Guanosine-rich oligonucleotide (GRO) compositions, methods and uses for treating respiratory syncytial virus infection
    Patent number: 9476049
    Abstract: Provided herein is a method of treating Respiratory Syncytial Virus (RSV) infection in a cell. The method involves administering the guanosine-rich oligonucleotide (GRO) AS 1411 (5?-GGTGGTGGTGG TTGTGGTGGTGGTGG-3?—also known as GR026B and AGRO100) to the cell.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: October 25, 2016
    Assignees: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO, HOSPITAL FOR SICK CHILDREN
    Inventors: Richard George Hegele, Peter Mastrangelo, Theo Moraes
  • GUANOSINE-RICH OLIGONUCLEOTIDE (GRO) COMPOSITIONS, METHODS AND USES FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION
    Publication number: 20150010618
    Abstract: Provided herein is a method of treating Respiratory Syncytial Virus (RSV) infection in a cell. The method involves administering the guanosine-rich oligonucleotide (GRO) AS 1411 (5?-GGTGGTGGTGG TTGTGGTGGTGGTGG-3?—also known as GR026B and AGRO100) to the cell.
    Type: Application
    Filed: February 15, 2013
    Publication date: January 8, 2015
    Applicant: University of Toronto
    Inventors: Richard George Hegele, Peter Mastrangelo, Theo Moraes